Trevi Therapeutics, Inc. (TRVI) › Shareholders' EquityTrevi Therapeutics, Inc. (TRVI) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2017: -$84.43M2018: -$109.49M2019: $54.55M2020: $27.28M2021: $17.07M2022: $107.46M2023: $82.55M2024: $99.64M2025: $183.24M$183.24M2017Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$183.24M+83.9%2024$99.64M+20.7%2023$82.55M-23.2%2022$107.46M+529.3%2021$17.07M-37.4%2020$27.28M-50.0%2019$54.55M+149.8%2018-$109.49M-29.7%2017-$84.43M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share